002589 瑞康医药
已收盘 07-10 15:00:00
资讯
新帖
简况
瑞康医药80后高管留置背后,10倍溢价收购疑云笼罩
新浪证券 · 07-10 02:39
瑞康医药80后高管留置背后,10倍溢价收购疑云笼罩
瑞康医药董秘被实施留置 公司回应
格隆汇 · 07-03
瑞康医药董秘被实施留置 公司回应
A股避雷针:瑞康医药董事、董秘及副总裁被采取留置措施;5天2板南京商旅上半年净利润预降67%至78%
金融界 · 07-03
A股避雷针:瑞康医药董事、董秘及副总裁被采取留置措施;5天2板南京商旅上半年净利润预降67%至78%
瑞康医药最新公告:董事、董秘及副总裁李喆被采取留置措施
证券之星 · 07-02
瑞康医药最新公告:董事、董秘及副总裁李喆被采取留置措施
瑞康医药:董事、董秘及副总裁李喆被采取留置措施
格隆汇 · 07-02
瑞康医药:董事、董秘及副总裁李喆被采取留置措施
瑞康医药收盘上涨1.01%,滚动市盈率229.27倍,总市值44.99亿元
金融界 · 07-01
瑞康医药收盘上涨1.01%,滚动市盈率229.27倍,总市值44.99亿元
每周股票复盘:瑞康医药(002589)股东减持及回购进展
证券之星 · 06-07
每周股票复盘:瑞康医药(002589)股东减持及回购进展
6月3日瑞康医药发布公告,股东减持0.01万股
证券之星 · 06-03
6月3日瑞康医药发布公告,股东减持0.01万股
【瑞康医药:控股股东终止协议转让公司部分股份】 瑞康医药晚间公告,因客观环境发生重大变化,公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定,张仁华将其持有的公司股份7600万股转让给岩泉8号基金,转让价格2.13元/股,总价款1.62亿元。
金融界 · 06-02
【瑞康医药:控股股东终止协议转让公司部分股份】 瑞康医药晚间公告,因客观环境发生重大变化,公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定,张仁华将其持有的公司股份7600万股转让给岩泉8号基金,转让价格2.13元/股,总价款1.62亿元。
瑞康医药:将于5月15日参加2025年山东辖区上市公司投资者网上集体接待日活动
中国财富通 · 05-14
瑞康医药:将于5月15日参加2025年山东辖区上市公司投资者网上集体接待日活动
瑞康医药(002589.SZ)股东荆州慧泽拟减持不超1%股份
智通财经 · 05-07
瑞康医药(002589.SZ)股东荆州慧泽拟减持不超1%股份
【瑞康医药:荆州慧泽拟减持不超1%公司股份】瑞康医药公告,公司持股5%以上股东荆州招商慧泽医药投资合伙企业计划以集中竞价交易或大宗交易方式减持不超过1504.71万股,占公司总股本的1%。
金融界 · 05-07
【瑞康医药:荆州慧泽拟减持不超1%公司股份】瑞康医药公告,公司持股5%以上股东荆州招商慧泽医药投资合伙企业计划以集中竞价交易或大宗交易方式减持不超过1504.71万股,占公司总股本的1%。
瑞康医药最新公告:股东拟减持不超过1%股份
证券之星 · 05-07
瑞康医药最新公告:股东拟减持不超过1%股份
瑞康医药收盘上涨1.02%,滚动市盈率228.50倍,总市值44.84亿元
金融界 · 05-06
瑞康医药收盘上涨1.02%,滚动市盈率228.50倍,总市值44.84亿元
瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升
证券之星 · 04-30
瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升
瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%
证券之星 · 04-30
瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%
【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。
金融界 · 04-30
【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。
图解瑞康医药一季报:第一季度单季净利润同比减6.58%
证券之星 · 04-29
图解瑞康医药一季报:第一季度单季净利润同比减6.58%
瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%
智通财经 · 04-29
瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%
加载更多
公司概况
公司名称:
瑞康医药集团股份有限公司
所属行业:
批发业
上市日期:
2011-06-10
主营业务:
瑞康医药集团股份有限公司的主营业务是药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块。公司的主要产品是药品、器械、移动医疗。
发行价格:
20.00
{"stockData":{"symbol":"002589","market":"SZ","secType":"STK","nameCN":"瑞康医药","latestPrice":3.04,"timestamp":1752131001000,"preClose":3,"halted":0,"volume":27303430,"delay":0,"changeRate":0.0133,"floatShares":1366000000,"shares":1505000000,"eps":0.0131,"marketStatus":"已收盘","change":0.04,"latestTime":"07-10 15:00:00","open":3,"high":3.05,"low":2.99,"amount":82763300,"amplitude":0.02,"askPrice":3.05,"askSize":23632,"bidPrice":3.04,"bidSize":569,"shortable":0,"etf":0,"ttmEps":0.0131,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752197400000},"marketStatusCode":5,"adr":0,"adjPreClose":3,"symbolType":"stock","openAndCloseTimeList":[[1752111000000,1752118200000],[1752123600000,1752130800000]],"highLimit":3.3,"lowLimit":2.7,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1504710471,"isCdr":false,"pbRate":0.82,"roa":"--","peRate":232.061069,"roe":"0.26%","epsLYR":0.0137,"committee":-0.421869,"marketValue":4574000000,"turnoverRate":0.02,"status":0,"floatMarketCap":4151000000},"requestUrl":"/m/hq/s/002589","defaultTab":"news","newsList":[{"id":"2550069510","title":"瑞康医药80后高管留置背后,10倍溢价收购疑云笼罩","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069510","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550069510?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:39","pubTimestamp":1752115140,"startTime":"0","endTime":"0","summary":"当瑞康医药的股份回购公告与高管留置通知同步发出,资本市场的疑虑已如潮水般蔓延。7月初,这家深陷业绩泥潭的医药企业突然公告:董事、董秘兼副总裁李喆被济南市济阳区监察委员会实施留置。 2025年2月,瑞康医药宣布以1.51亿元收购浙江衡玖医疗器械76.01%股权。 对瑞康医药而言,留置事件掀开的或是更深层的治理冰山,而10倍溢价收购疑云,正成为检验其生存韧性的试金石。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-07-10/doc-infeyanw0498455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","BK0250","002589","BK0185","BK0077","BK0070","BK0197"],"gpt_icon":0},{"id":"2548825174","title":"瑞康医药董秘被实施留置 公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2548825174","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548825174?lang=zh_cn&edition=full","pubTime":"2025-07-03 11:38","pubTimestamp":1751513896,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0250","BK0197","002589","BK0132","BK0185","BK0077","BK0070"],"gpt_icon":0},{"id":"2548984959","title":"A股避雷针:瑞康医药董事、董秘及副总裁被采取留置措施;5天2板南京商旅上半年净利润预降67%至78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548984959","media":"金融界","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548984959?lang=zh_cn&edition=full","pubTime":"2025-07-03 08:05","pubTimestamp":1751501107,"startTime":"0","endTime":"0","summary":"【重要事项】瑞康医药:董事、董秘及副总裁被采取留置措施永太科技:公司可能涉及诉讼,但尚未收到相关材料5连板诚邦股份:子公司芯存电子目前业务规模较小4连板亚星化学:股票连续四日累计涨幅超33%,一季度亏损扩大3连板西上海:涨幅显著高于行业及大盘,一季度净利润亏损4天3板昂利康:ALK-N001项目尚处于I期临床试验阶段天赐材料:子公司向永太科技等提起商业秘密侵权诉讼,涉案金额预期经济损失8.87亿元","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/07/03080551452960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159982","600250","002589","399300"],"gpt_icon":0},{"id":"2548924958","title":"瑞康医药最新公告:董事、董秘及副总裁李喆被采取留置措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2548924958","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548924958?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:49","pubTimestamp":1751460576,"startTime":"0","endTime":"0","summary":"瑞康医药(002589.SZ)公告称,公司董事、董事会秘书及副总裁李喆被济南市济阳区监察委员会实施留置措施。在李喆被留置期间,由公司证券事务代表王秀婷代行董事会秘书职责。目前,公司拥有完善的治理结构和内部控制机制,除李喆外,其他董事、监事和其他高级管理人员均正常履职。公司及子公司生产经营秩序正常,本事项不会对公司正常生产经营产生重大影响。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200036345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589","BK0132","BK0070","BK0250","BK0197","BK0077","BK0185"],"gpt_icon":0},{"id":"2548689231","title":"瑞康医药:董事、董秘及副总裁李喆被采取留置措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2548689231","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548689231?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:46","pubTimestamp":1751460416,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0070","BK0077","002589","BK0132","161027","BK0185","BK0250","BK0197"],"gpt_icon":0},{"id":"2548071601","title":"瑞康医药收盘上涨1.01%,滚动市盈率229.27倍,总市值44.99亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071601","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548071601?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:44","pubTimestamp":1751359466,"startTime":"0","endTime":"0","summary":"7月1日,瑞康医药今日收盘2.99元,上涨1.01%,滚动市盈率PE达到229.27倍,创14天以来新低,总市值44.99亿元。从行业市盈率排名来看,公司所处的医药商业行业市盈率平均44.11倍,行业中值27.97倍,瑞康医药排名第28位。资金流向方面,7月1日,瑞康医药主力资金净流出549.11万元,近5日总体呈流出状态,5日共流出573.22万元。瑞康医药集团股份有限公司的主营业务是药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/01164451412954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0250","BK0197","BK0185","BK0132","002589","BK0077","BK0070"],"gpt_icon":0},{"id":"2541673890","title":"每周股票复盘:瑞康医药(002589)股东减持及回购进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2541673890","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541673890?lang=zh_cn&edition=full","pubTime":"2025-06-07 11:27","pubTimestamp":1749266829,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘,瑞康医药报收于2.99元,较上周的2.98元上涨0.34%。本周,瑞康医药6月4日盘中最高价报3.04元。本次变动前,信息披露义务人持有瑞康医药75,235,525股,占公司总股本的5.00%。截至报告书签署日,除已披露的减持行为外,信息披露义务人在过去六个月内未买卖瑞康医药股票。本次终止事宜符合相关法律法规规定,不存在违反尚在履行的承诺的情形。本次回购股份符合公司既定的回购股份方案及相关法律法规的要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0197","002589","BK0250","BK0077","BK0185","BK0070"],"gpt_icon":0},{"id":"2540700837","title":"6月3日瑞康医药发布公告,股东减持0.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2540700837","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540700837?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:45","pubTimestamp":1748961937,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日瑞康医药发布公告《瑞康医药:简式权益变动报告书》,其股东荆州招商慧泽医药投资合伙企业(有限合伙)于2025年5月30日合计减持0.01万股,占公司目前总股本的0.0%,变动期间该股股价上涨0.68%,截止5月30日收盘报2.98元。股东增减持详情见下表:根据瑞康医药2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060300036601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0250","BK0070","BK0185","BK0077","002589","BK0197"],"gpt_icon":0},{"id":"2540676555","title":"【瑞康医药:控股股东终止协议转让公司部分股份】 瑞康医药晚间公告,因客观环境发生重大变化,公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定,张仁华将其持有的公司股份7600万股转让给岩泉8号基金,转让价格2.13元/股,总价款1.62亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540676555","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540676555?lang=zh_cn&edition=full","pubTime":"2025-06-02 16:04","pubTimestamp":1748851472,"startTime":"0","endTime":"0","summary":"瑞康医药晚间公告,因客观环境发生重大变化,公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定,张仁华将其持有的公司股份7600万股转让给岩泉8号基金,转让价格2.13元/股,总价款1.62亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/02160450809333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0250","BK0197","BK0185","BK0132","002589","BK0077","BK0070"],"gpt_icon":0},{"id":"2535011374","title":"瑞康医药:将于5月15日参加2025年山东辖区上市公司投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2535011374","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535011374?lang=zh_cn&edition=full","pubTime":"2025-05-14 17:00","pubTimestamp":1747213204,"startTime":"0","endTime":"0","summary":"5月14日,瑞康医药(002589)公告称,为进一步加强与投资者的互动交流,公司将参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2025年山东辖区上市公司投资者网上集体接待日活动”,本次活动将采用网络远程的方式举行,投资者可通过登录“全景路演”网站等方式参与本次互动交流。活动时间为2025年5月15日(周四)15:00-16:30。届时公司高管将在线就公司经营状况等投资者关心的问题,与投资者进行沟通与交流。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=3uqCeDsVeBs%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0197","002589","BK0185","BK0132","BK0070","BK0077","BK0250"],"gpt_icon":0},{"id":"2533393699","title":"瑞康医药(002589.SZ)股东荆州慧泽拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533393699","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533393699?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:53","pubTimestamp":1746626007,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)发布公告,股东荆州招商慧泽医药投资合伙企业(有限合伙)计划以集中竞价交易或大宗交易的方式减持公司股份不超过1504.71万股,即不超过公司总股本的1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK0132","BK0077","BK0197","BK0070","BK0250","002589"],"gpt_icon":0},{"id":"2533294936","title":"【瑞康医药:荆州慧泽拟减持不超1%公司股份】瑞康医药公告,公司持股5%以上股东荆州招商慧泽医药投资合伙企业计划以集中竞价交易或大宗交易方式减持不超过1504.71万股,占公司总股本的1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294936","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533294936?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:42","pubTimestamp":1746625337,"startTime":"0","endTime":"0","summary":"瑞康医药公告,公司持股5%以上股东荆州招商慧泽医药投资合伙企业计划以集中竞价交易或大宗交易方式减持不超过1504.71万股,占公司总股本的1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07214250207933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002589","BK0077","BK0250","09939","BK1161","BK1574","BK0185","BK0070","BK0197","159938","BK1515","BK0132"],"gpt_icon":0},{"id":"2533363619","title":"瑞康医药最新公告:股东拟减持不超过1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533363619","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533363619?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:41","pubTimestamp":1746625275,"startTime":"0","endTime":"0","summary":"瑞康医药(002589.SZ)公告称,持股5%以上股东荆州招商慧泽医药投资合伙企业(有限合伙)计划以集中竞价交易或大宗交易的方式减持公司股份不超过15,047,105股,即不超过公司总股本的1%。减持时间为自公告之日起15个交易日后的3个月内。减持完成后,荆州慧泽将不再是公司持股5%以上股东。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700035803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0132","002589","BK0077","BK0185","BK0070","BK0250"],"gpt_icon":0},{"id":"2533570687","title":"瑞康医药收盘上涨1.02%,滚动市盈率228.50倍,总市值44.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533570687","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533570687?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:08","pubTimestamp":1746522531,"startTime":"0","endTime":"0","summary":"5月6日,瑞康医药今日收盘2.98元,上涨1.02%,滚动市盈率PE达到228.50倍,创20天以来新低,总市值44.84亿元。从行业市盈率排名来看,公司所处的医药商业行业市盈率平均36.40倍,行业中值27.40倍,瑞康医药排名第29位。截至2025年一季报,共有4家机构持仓瑞康医药,其中其他4家,合计持股数12046.78万股,持股市值3.48亿元。瑞康医药集团股份有限公司的主营业务包含药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块五大业务板块。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/06170850158800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0250","BK0185","002589","BK0077","BK0132","BK0070","BK0197"],"gpt_icon":0},{"id":"2532001354","title":"瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2532001354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532001354?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:55","pubTimestamp":1746053733,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期瑞康医药发布2025年一季报。截至本报告期末,公司营业总收入17.57亿元,同比下降12.98%,归母净利润1417.11万元,同比下降6.58%。本报告期瑞康医药盈利能力上升,毛利率同比增幅14.98%,净利率同比增幅20.27%。去年的净利率为0.51%,算上全部成本后,公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100005540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2531086453","title":"瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531086453","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531086453?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:51","pubTimestamp":1746006684,"startTime":"0","endTime":"0","summary":"证券之星消息,近日瑞康医药披露,截至2025年3月31日公司股东户数为7.76万户,较1月27日减少2663.0户,减幅为3.32%。在医药商业行业个股中,瑞康医药股东户数高于行业平均水平,截至3月31日,医药商业行业平均股东户数为4.1万户。从股价来看,2025年1月27日至2025年3月31日,瑞康医药区间涨幅为4.33%,在此期间股东户数减少2663.0户,减幅为3.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000036642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0132","BK0197","002589","BK0070","BK0250","BK0185"],"gpt_icon":0},{"id":"2531246771","title":"【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531246771","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531246771?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:06","pubTimestamp":1745993167,"startTime":"0","endTime":"0","summary":"医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30140650037793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0209","603716","BK1515","09939","BK0250","BK1574","BK0132","BK0185","301017","BK0070","BK1161","BK0077","BK0197","603883","600713","002589","159938"],"gpt_icon":0},{"id":"2531798533","title":"图解瑞康医药一季报:第一季度单季净利润同比减6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531798533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531798533?lang=zh_cn&edition=full","pubTime":"2025-04-30 02:45","pubTimestamp":1745952356,"startTime":"0","endTime":"0","summary":"证券之星消息,瑞康医药2025年一季报显示,公司主营收入17.57亿元,同比下降12.98%;归母净利润1417.11万元,同比下降6.58%;扣非净利润1003.38万元,同比下降44.75%;负债率64.53%,投资收益523.3万元,财务费用4917.17万元,毛利率13.85%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000001675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2531752074","title":"瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531752074?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:24","pubTimestamp":1745940285,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)发布2025年一季度报告,第一季度,公司实现营业收入17.57亿元,同比下降12.98%。归属于上市公司股东的净利润1417.11万元,同比下降6.58%。归属于上市公司股东的扣除非经常性损益的净利润1003.38万元,同比下降44.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002589"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752192896305,"stockEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0912},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.4126},{"period":"ytd","weight":0.0249}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0838},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.194},{"period":"ytd","weight":0.0471}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"瑞康医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"115999人(较上一季度减少1.14%)","perCapita":"11772股","listingDate":"2011-06-10","address":"山东省烟台市芝罘区凤鸣路103号13号楼","registeredCapital":"150471万元","survey":" 瑞康医药集团股份有限公司的主营业务是药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块。公司的主要产品是药品、器械、移动医疗。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞康医药,002589,瑞康医药股票,瑞康医药股票老虎,瑞康医药股票老虎国际,瑞康医药行情,瑞康医药股票行情,瑞康医药股价,瑞康医药股市,瑞康医药股票价格,瑞康医药股票交易,瑞康医药股票购买,瑞康医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}